Skip to main content
. 2022 Apr 21;15:505–515. doi: 10.2147/JAA.S363398

Figure 2.

Figure 2

(A) FEV1/FVC (%) variation during omalizumab therapy. (B FEV1 (%) variation during omalizumab therapy. (C) total IgE levels (IU/mL) variation during omalizumab therapy.

Abbreviation: FEV1, forced expiratory volume in 1 second; FEV1/FVC, forced expiratory volume in 1 second/forced vital capacity; IgE, immunoglobulin E.